Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature

A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang, R. Buckstein

Journal of Cancer Therapy Vol.6 No.1

Full-Text HTML XML   Pub. Date: December 26, 2014

DOI: 10.4236/jct.2015.61001   3,551 Downloads  4,330 Views  Citations
This article belongs to the Special Issue on Advances in Lymphoma Research